ImmuCell Corporation Financial Ratios — ICCC Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	-4.47	0.98	1.26	-1.79	12.21	3.35	-0.78	-10.24	-5.11	-3.57	-0.26	-7.92	-20.86	-8.21	-3.81
Return on Assets (%)	-3.77	0.81	1.07	-1.52	9.48	2.59	-0.57	-6.93	-3.63	-2.59	-0.18	-5.58	-13.03	-4.85	-2.37
Return on Capital (%)	- -	1.19	1.49	- -	10.54	3.38	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	1.09	-0.11	- -	10.42	3.27	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	55.05	56.67	50.95	58.56	61.11	56.8	50.06	47.28	49.11	44.73	44.98	41.19	22.15	29.97	41.4
EBITDA Margin (%)	-4.19	12.01	6.62	3.19	25.89	17.73	6.34	-5.7	9.57	6.3	14.13	1.02	-17.35	3.95	15.84
Operating Margin (%)	-12.38	4.55	-0.33	-2.72	20.75	9.33	-2.33	-19.54	-6.95	-9	1.34	-12.38	-32.9	-6.19	5.97
Incremental Operating Margin (%)	- -	314.83	- -	- -	88.48	179.94	- -	- -	- -	- -	41.99	- -	-12.38	- -	285.79
Pretax Margin (%)	-13.63	3.57	3.42	-3.36	20.17	7.95	-4.2	-16.93	-9.24	-6.73	-0.36	-13.39	-33.02	-8.1	-3.72
Profit Margin (%)	-8.01	1.66	1.95	-2.2	11.86	5.33	-1.61	-21.13	-9.44	-6.66	-0.41	-13.43	-33.05	-8.14	-3.76
Net Income to Common Margin (%)	-8.01	1.66	1.95	-2.2	11.86	5.33	-1.61	-21.13	-9.44	-6.66	-0.41	-13.43	-33.05	-8.14	-3.76
Effective Tax Rate (%)	- -	53.42	42.81	- -	41.21	32.95	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	-4.47	0.98	1.26	-1.79	12.21	3.35	-0.78	-10.24	-5.11	-3.57	-0.26	-7.92	-20.86	-8.21	-3.81

Credit (USD)

Credit Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	1	1	1	1	3	3	9	10	8	11	10	12	17	15	13
ST Debt	- -	- -	- -	- -	- -	- -	- -	1	1	1	1	1	2	2	2
LT Debt	1	1	1	1	3	3	9	8	7	10	9	11	15	13	11
Total Debt/EBITDA	-6.72	1.96	2.73	3.7	1.2	1.78	13.54	-15.6	6.41	11.1	3.78	66.16	-5.51	14.42	3.01
Net Debt/EBITDA	-3.08	-2.17	-2.98	0.19	0.61	-1.26	7.79	-11.58	1.62	2.63	-0.38	23.53	-3.63	6.48	1.21
Total Debt/EBIT	-2.28	5.18	-55.58	-4.34	1.5	3.38	-36.88	-4.55	-8.83	-7.78	39.92	-5.43	-2.9	-9.21	8
Net Debt/EBIT	-1.04	-5.74	60.54	-0.22	0.76	-2.4	-21.24	-3.38	-2.23	-1.85	-4.06	-1.93	-1.91	-4.13	3.21
EBITDA to Interest Expense	-2.63	8.6	5.96	4.19	31.69	10.47	3.03	-1.46	3.04	2.34	8.87	0.54	-6.69	1.99	9.97
EBITDA-CapEx/Interest Expense	-5.63	4.94	-3	-22.36	-0.85	-11.71	-78.23	-6.21	-0.18	-7.53	0.36	-10.86	-10.87	1.11	7.13
EBIT to Interest Expense	-7.77	3.25	-0.29	-3.57	25.39	5.51	-1.11	-5.02	-2.21	-3.34	0.84	-6.6	-12.69	-3.12	3.76
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	- -
Common Equity/Total Assets	82.07	83.36	85.72	83.77	73	79.86	68.79	66.43	74.93	70.05	73.26	67.72	57.05	61.02	63.61
Long-Term Debt/Equity (%)	14.06	11.82	9.54	8.06	28.78	14.6	36.61	38.73	24.65	34.93	28.71	37.55	58.49	47.86	42.5
Long-Term Debt/Capital (%)	12.12	10.39	8.55	7.35	22.14	12.66	26.54	26.73	19.1	25.31	21.83	26.62	35.07	30.9	28.57
Long-Term Debt/Total Assets (%)	11.54	9.85	8.18	6.75	21.01	11.66	25.19	25.73	18.47	24.47	21.04	25.43	33.37	29.2	27.04
Total Debt/Equity (%)	15.97	13.79	11.56	9.68	30.02	15.27	37.96	44.91	29.05	37.97	31.54	41.08	66.78	54.87	48.77
Total Debt/Capital (%)	13.77	12.12	10.37	8.83	23.09	13.25	27.51	30.99	22.51	27.52	23.98	29.12	40.04	35.43	32.78
Total Debt/Total Assets (%)	13.11	11.5	9.91	8.11	21.91	12.2	26.11	29.84	21.77	26.6	23.11	27.82	38.1	33.48	31.02
Net Debt to Equity	7.31	-15.29	-12.6	0.5	15.19	-10.84	21.86	33.32	7.34	9.01	-3.21	14.61	43.97	24.64	19.56
Net Debt/Capital (%)	6.81	-18.05	-14.41	0.5	13.19	-12.16	17.94	24.99	6.84	7.95	-3.2	11.98	27	17.45	14.52
EBITDA	- -	1	- -	- -	3	2	1	-1	1	1	3	- -	-3	1	4
EBITDA-CapEx	- -	- -	- -	-1	- -	-2	-17	-3	- -	-3	- -	-4	-5	1	3
Operating Income (Loss)	-1	- -	- -	- -	2	1	- -	-2	-1	-1	- -	-2	-6	-2	2

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	7.81	7.38	8.27	3.31	7.62	5.16	1.84	0.98	3.52	3.59	4.02	1.89	0.23	0.85	0.96
Current Ratio	11.26	11.06	11.43	5.42	9.94	6.97	3.64	2.5	5.29	5.5	6.42	4.56	2.73	3.41	4.26
Quick Ratio	8.41	8.3	9.26	4.31	8.56	5.71	2.56	1.54	4.19	4.44	5.09	2.47	0.76	1.72	1.82
CFO/Avg Current Liab	-0.06	0.53	1.69	0.37	3.22	-0.16	0.57	-0.16	0.09	0.56	0.4	-0.55	-1.29	0.08	0.59
Common Equity/Total Assets	82.07	83.36	85.72	83.77	73	79.86	68.79	66.43	74.93	70.05	73.26	67.72	57.05	61.02	63.61
Long-Term Debt/Equity (%)	14.06	11.82	9.54	8.06	28.78	14.6	36.61	38.73	24.65	34.93	28.71	37.55	58.49	47.86	42.5
Long-Term Debt/Capital (%)	12.12	10.39	8.55	7.35	22.14	12.66	26.54	26.73	19.1	25.31	21.83	26.62	35.07	30.9	28.57
Long-Term Debt/Total Assets (%)	11.54	9.85	8.18	6.75	21.01	11.66	25.19	25.73	18.47	24.47	21.04	25.43	33.37	29.2	27.04
Total Debt/Equity (%)	15.97	13.79	11.56	9.68	30.02	15.27	37.96	44.91	29.05	37.97	31.54	41.08	66.78	54.87	48.77
Total Debt/Capital (%)	13.77	12.12	10.37	8.83	23.09	13.25	27.51	30.99	22.51	27.52	23.98	29.12	40.04	35.43	32.78
Total Debt/Total Assets (%)	13.11	11.5	9.91	8.11	21.91	12.2	26.11	29.84	21.77	26.6	23.11	27.82	38.1	33.48	31.02
CFO/Total Liabilities	-1.89	18.76	70.21	16.86	73.86	-4.47	10.98	-3.4	2.41	10.89	8.03	-10.66	-24.84	2.04	15.99
CFO/CapEx	-0.15	1.25	1.84	0.2	1.07	-0.06	0.07	-0.18	0.17	0.32	0.37	-0.39	-2.47	0.77	1.98
Altman's Z-Score	5.16	5.17	6.17	5.96	5.35	4.66	3.21	2.35	2.81	2.57	3.83	2.3	1.04	1.89	2.8

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	12.59	11.25	9.95	9.59	11.99	11.16	8.93	9.65	10.68	8.94	8.57	8.34	8.86	8.9	7.69
Days Sales Outstanding	28.98	32.43	36.67	38.06	30.45	32.71	40.88	37.81	34.17	40.85	42.59	43.77	41.2	41.03	47.47
Inventory Turnover	1.41	1.41	2.06	2.93	4.38	2.75	2.49	2.64	2.88	3.68	4.09	2.39	1.96	2.49	1.98
Days Inventory Outstanding	259.57	259.06	176.86	124.78	83.32	132.65	146.31	138.04	126.75	99.24	89.34	152.57	185.83	146.81	184.54
Accounts Payable Turnover	18.49	12.25	11.08	8.5	11.88	6.3	3.76	6.65	12.19	13.71	17.2	18.07	18.33	19.5	21.1
Accounts Payable Turnover Days	19.74	29.8	32.94	42.95	30.72	57.93	97.04	54.85	29.93	26.62	21.23	20.2	19.91	18.72	17.3
Cash Conversion Cycle	268.81	261.68	180.59	119.9	83.05	107.43	90.15	121.01	130.99	113.47	110.7	176.14	207.11	169.12	214.71
Inventory to Cash Days	-230.58	-226.63	-140.19	-86.72	-52.86	-99.95	-105.43	-100.23	-92.58	-58.39	-46.74	-108.81	-144.63	-105.78	-137.07
Inventories	2	2	1	1	1	2	2	2	3	2	3	6	8	7	9
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	1	1	1	2	2	1	2
Work In Process	1	1	1	- -	- -	1	1	1	1	1	2	3	6	6	6
Finished Goods	- -	- -	- -	- -	- -	1	- -	1	1	- -	- -	- -	- -	- -	2
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	14	12	13	15	23	29	48	39	37	43	62	47	39	46	56
- Cash & Cash Equivalents	1	3	2	1	2	5	4	3	6	7	10	6	1	4	4
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	1	1	1	1	3	3	9	10	8	11	10	12	17	15	13
Enterprise Value	10	8	9	12	20	21	53	46	37	46	62	54	55	58	65
Total Capital	10	10	10	10	14	23	33	32	37	39	43	43	42	43	40
Total Debt/Capital (%)	13.77	12.12	10.37	8.83	23.09	13.25	27.51	30.99	22.51	27.52	23.98	29.12	40.04	35.43	32.78
Total Debt / EV	0.14	0.15	0.12	0.07	0.16	0.14	0.17	0.21	0.23	0.23	0.17	0.23	0.3	0.26	0.2
EV/Sales	2.04	1.56	1.46	1.61	1.97	2.22	5.11	4.23	2.68	2.98	3.22	2.91	3.16	2.17	2.35
EV/EBITDA	- -	13.02	22	50.59	7.62	12.54	80.55	- -	28.01	47.3	22.82	285.96	- -	55	14.85
EV/EBIT	- -	34.41	- -	- -	9.51	23.85	- -	- -	- -	- -	240.98	- -	- -	- -	39.42
EV/Cash Flow to Firm	992.39	22.22	7.7	36.06	6.84	- -	42.31	289.56	54.52	26.53	47.66	- -	- -	64.96	22.27
EV/Free Cash Flow to Firm	41.1	12.87	5.04	6.54	3.56	6.11	2.8	21.22	17.81	7.89	15.86	19.4	- -	42.59	15.59
Diluted Market Cap	14	12	13	15	24	26	44	39	35	43	61	47	39	42	56
Diluted Enterprise Value	15	11	12	15	25	24	49	46	37	47	61	54	55	53	65
EV per Share	3.48	2.79	2.89	4.05	6.6	4.38	9.73	8.35	5.1	6.34	8.01	6.96	7.12	6.41	7.19
TTM Sales	5	5	6	8	10	10	10	11	14	15	19	19	17	26	28
TTM EBITDA	- -	1	- -	- -	3	2	1	-1	1	1	3	- -	-3	1	4
TTM Operating Income	-1	- -	- -	- -	2	1	- -	-2	-1	-1	- -	-2	-6	-2	2
TTM Cash Flow to Firm	- -	- -	1	- -	3	- -	1	- -	1	2	1	-1	-4	1	3
TTM Free Cash Flow to Firm	- -	1	2	2	6	3	19	2	2	6	4	3	-2	1	4

Multiples (USD)

Valuation Multiples API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	67.24	20.06	7.76	8	4.25	7.67	2.3	23.34	21.61	7.97	17.05	19.43	-14.18	51.07	14.9
EV/EBIT	- -	34.41	- -	- -	9.51	23.85	- -	- -	- -	- -	240.98	- -	- -	- -	39.42
Enterprise Value	10	8	9	12	20	21	53	46	37	46	62	54	55	58	65
Low Price	2.91	3.76	3.19	3.3	4.99	4.76	5	6.38	4.7	3.7	5.73	5.98	4.26	3.34	4.28
EV/Sales	2.04	1.56	1.46	1.61	1.97	2.22	5.11	4.23	2.68	2.98	3.22	2.91	3.16	2.17	2.35
EV/EBITDA	- -	13.02	22	50.59	7.62	12.54	80.55	- -	28.01	47.3	22.82	285.96	- -	55	14.85
Price/Earnings	- -	134.88	109.8	- -	18.91	49.45	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	-36.39	173.22	100.77	-81.78	17.84	55.68	-194.44	-17.37	-32.16	-36.47	-909.57	-25.37	-7.22	-16.84	-50.37
Price/Earnings High	-61.95	236.03	131.17	-102.85	28.59	68.9	-272.25	-21.98	-43.58	-57.37	-1,280.01	-34.04	-10.52	-22.04	-65.96
Price/Earnings Low	-21.21	126.79	82.05	-59.76	12.51	39.56	-147.16	-15.08	-24.74	-26.11	-555.64	-18.57	-5.72	-12.65	-37.14
Price/Book Value	1.55	1.31	1.37	1.59	2.17	1.46	2.04	1.8	1.28	1.52	1.9	1.56	1.58	1.68	2.06
Price/Book Value Average	1.66	1.69	1.26	1.48	2.05	1.65	1.53	1.88	1.52	1.32	2.23	2.08	1.67	1.45	1.94
Price/Book Value High	2.83	2.3	1.64	1.86	3.28	2.04	2.15	2.38	2.06	2.08	3.14	2.79	2.43	1.9	2.54
Price/Book Value Low	0.97	1.23	1.03	1.08	1.44	1.17	1.16	1.63	1.17	0.94	1.36	1.52	1.32	1.09	1.43
Price/Tangible Book Value	1.55	1.31	1.37	1.59	2.17	1.48	2.06	1.82	1.29	1.53	1.91	1.56	1.59	1.69	2.06
Price/Tangible Book Value Average	1.66	1.69	1.26	1.48	2.05	1.67	1.55	1.9	1.53	1.33	2.24	2.09	1.68	1.46	1.95
Price/Tangible Book Value High	2.83	2.3	1.64	1.86	3.28	2.07	2.17	2.41	2.08	2.09	3.15	2.81	2.44	1.91	2.55
Price/Tangible Book Value Low	0.97	1.23	1.03	1.08	1.44	1.19	1.17	1.65	1.18	0.95	1.37	1.53	1.33	1.09	1.44
Price/Sales	2.72	2.24	2.15	1.94	2.24	2.63	4.17	3.52	2.56	2.8	3.16	2.54	2.26	1.59	2.01
Price/Sales Average	2.92	2.88	1.97	1.8	2.12	2.97	3.13	3.67	3.04	2.43	3.7	3.41	2.39	1.37	1.89
Price/Sales High	4.96	3.92	2.56	2.26	3.39	3.67	4.39	4.64	4.11	3.82	5.21	4.57	3.48	1.79	2.48
Price/Sales Low	1.7	2.11	1.6	1.31	1.48	2.11	2.37	3.19	2.34	1.74	2.26	2.49	1.89	1.03	1.4
Price/Cash Flow	-371.94	35.06	11.73	48.65	7.91	-113.1	37	-103.53	150.39	32.62	63.65	-30.6	-8.44	117.52	22.43
Price/Cash Flow Average	-399.39	45.02	10.77	45.21	7.46	-127.33	27.81	-108	178.45	28.33	74.63	-40.97	-8.92	101.48	21.16
Price/Cash Flow High	-679.9	61.35	14.02	56.86	11.96	-157.58	38.93	-136.63	241.79	44.57	105.03	-54.98	-13	132.81	27.71
Price/Cash Flow Low	-232.76	32.95	8.77	33.04	5.23	-90.48	21.04	-93.73	137.25	20.29	45.59	-30	-7.06	76.22	15.61
Price/Free Cash Flow Average	72.2	25.76	7.13	7.44	4.01	8.63	1.73	24.35	25.64	6.92	19.99	26.02	-14.99	44.1	14.06
Price/Free Cash Flow High	122.91	35.11	9.28	9.35	6.42	10.69	2.42	30.8	34.75	10.88	28.13	34.91	-21.84	57.71	18.41
Price/Free Cash Flow Low	42.08	18.86	5.8	5.43	2.81	6.14	1.31	21.13	19.72	4.95	12.21	19.05	-11.87	33.12	10.37
EV/Sales Average	3.06	2.62	1.78	1.81	2.28	3.18	3.96	4.39	3.37	2.68	3.78	3.77	3.29	1.94	2.24
EV/Sales High	5.12	3.66	2.37	2.27	3.56	3.99	5.35	5.37	4.51	4.07	5.32	4.93	4.38	2.4	2.83
EV/Sales Low	1.84	1.85	1.41	1.32	1.65	2.19	3.12	3.89	2.63	1.99	2.31	2.86	2.79	1.56	1.74
EV/EBITDA Average	-73.05	21.78	26.84	56.56	8.82	17.92	62.48	-76.99	35.18	42.49	26.75	370.88	-18.95	48.97	14.13
EV/EBITDA High	-122.2	30.47	35.83	71.08	13.76	22.48	84.36	-94.33	47.09	64.61	37.62	485.55	-25.23	60.74	17.84
EV/EBITDA Low	-43.86	15.36	21.3	41.38	6.37	12.37	49.18	-68.35	27.43	31.54	16.35	281.03	-16.08	39.48	10.99
EV/EBIT Average	-24.75	57.56	-545.81	-66.46	11	34.08	-170.21	-22.45	-48.44	-29.76	282.48	-30.43	-9.99	-31.26	37.52
EV/EBIT High	-41.4	80.52	-728.77	-83.53	17.17	42.74	-229.82	-27.5	-64.84	-45.26	397.39	-39.84	-13.31	-38.78	47.38
EV/EBIT Low	-14.86	40.6	-433.17	-48.62	7.94	23.52	-133.99	-19.93	-37.77	-22.09	172.7	-23.06	-8.48	-25.2	29.17
Last Price	4.65	4	4.27	4.86	7.54	5.95	8.79	7.05	5.15	5.95	8	6.1	5.09	5.15	6.15
High Price	8.5	7	5.1	5.68	11.4	8.29	9.25	9.3	8.28	8.13	13.2	10.96	7.84	5.82	7.6
Enterprise Value Average	16	14	11	14	23	30	41	48	46	41	73	70	57	51	62
Enterprise Value High	26	20	14	17	36	38	56	59	62	62	102	92	76	64	78
Enterprise Value Low	9	10	8	10	17	21	33	43	36	30	44	53	49	41	48

Shares Outstanding	3	3	3	3	3	5	5	6	7	7	8	8	8	9	9
Diluted Weighted Avg Shares	3	3	3	3	3	4	5	5	7	7	8	8	8	8	9
Basic Weighted Avg Shares	3	3	3	3	3	4	5	5	7	7	8	8	8	8	9
Revenue per Share	1.71	1.79	1.99	2.51	3.36	2.26	2.11	2	2.01	2.13	2.53	2.4	2.25	3.24	3.06
EBITDA per Share	-0.07	0.21	0.13	0.08	0.87	0.4	0.13	-0.11	0.19	0.13	0.36	0.02	-0.39	0.13	0.49
Operating Income per Share	-0.21	0.08	-0.01	-0.07	0.7	0.21	-0.05	-0.39	-0.14	-0.19	0.03	-0.3	-0.74	-0.2	0.18
Basic EPS, GAAP	-0.14	0.03	0.04	-0.06	0.4	0.12	-0.03	-0.42	-0.19	-0.14	-0.01	-0.32	-0.75	-0.26	-0.12
Basic EPS from Cont Ops	-0.14	0.03	0.04	-0.06	0.4	0.12	-0.03	-0.42	-0.19	-0.14	-0.01	-0.32	-0.75	-0.26	-0.12
Diluted EPS, GAAP	-0.14	0.03	0.04	-0.06	0.38	0.12	-0.03	-0.42	-0.19	-0.14	-0.01	-0.32	-0.75	-0.26	-0.12
Diluted EPS from Cont Ops	-0.14	0.03	0.04	-0.06	0.38	0.12	-0.03	-0.42	-0.19	-0.14	-0.01	-0.32	-0.75	-0.26	-0.12
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-0.01	0.11	0.36	0.1	0.95	-0.05	0.24	-0.07	0.03	0.18	0.13	-0.2	-0.6	0.04	0.27
Free Cash Flow per Basic Share	-0.09	0.02	0.17	-0.41	0.06	-0.9	-3.35	-0.44	-0.17	-0.38	-0.22	-0.71	-0.85	-0.01	0.14
Cash & Equivalents per Share	1.65	1.63	1.74	1.1	1.98	2.19	0.69	0.45	1.22	1.1	1.32	0.75	0.13	0.42	0.42
Book Value per Share	3	3.05	3.11	3.06	3.47	4.07	4.31	3.9	4.02	3.92	4.21	3.92	3.22	3.06	2.99
Tangible Book Value per Share	3	3.05	3.11	3.06	3.47	4.01	4.26	3.86	3.99	3.89	4.19	3.9	3.21	3.05	2.98

ImmuCell Corporation

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)